IPQ Inside the global regulatory dialogue

CMC Priorities of EFPIA’s European Biopharmaceutical Enterprises Include ADCs, Drug/Device Combos and Statistics

Jul 11th, 2018

Please Log in to print the full article

The EBE/EMA dialogue on the DDC issues, as well as on other of the pressing biotech manufacturing topics EBE is engaged with, continued at EMA Biologics Working Party (BWP) “interested parties” meeting held in London...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2019 IPQ Publications